The U.S. Food and Drug Administration (FDA) gave 510(k) clearance to Delphinus Medical Technologies Inc. for its SoftVue whole breast ultrasound tomography system, approved for diagnostic breast imaging.

Men with enlarged prostates can find relief with a non-surgical treatment that shrinks the gland, suggests research done on more than 100 patients and presented at the 26th annual International Symposium on Endovascular Therapy (ISET).

iCRco, a global leader in medical-imaging products, announced that it has partnered with the Filipino American Television Network (FILAM TV) in an effort to help those impacted by the devastating Typhoon Haiyan in the Philippines. iCRco has donated three VertX single-plate CR units with onboard touchscreen acquisition workstations and mobile carts to restore diagnostic imaging capability for residents of the area devastated by Typhoon Haiyan.

New Jersey Governor Chris Christie has signed the state’s breast density inform/insurance bill (S792) into law. New Jersey becomes the 14th state to enact and raises to  48 percent the number of American women living in states with mandatory breast density notification. 

OptionElite Retrievable Inferior Vena Cava

An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based tracer contrast agent to be used with positron emission tomography (PET) imaging to help identify dangerous inflammation and high-risk vulnerable atherosclerotic plaque inside vessel walls that causes acute heart attacks and strokes.

Therapy Cool Flex Ablation Catheter

ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy
ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy
ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy

Physicists at the McLaren Proton Therapy Center (MPTC) in Flint, Michigan conducted clinical testing of ProTom International, Inc.’s Radiance 330 Proton Therapy System.

Cianna Medical, Inc., a women’s health company, today announced the outcomes of a large, retrospective study demonstrating the safety and efficacy of the SAVI breast brachytherapy applicator. Researchers reported favorably low recurrence rates, high rates of survival and excellent cosmetic outcomes. SAVI is a strut-based applicator that delivers a form of accelerated partial breast irradiation (APBI) known as breast brachytherapy, a 5-day course of targeted radiation for early-stage breast cancer.

Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the diagnosis of cancer, announced today that the first 100 patients have been enrolled into its Pivotal Study of Imagio, a new opto-acoustic imaging system that may help women with benign breast masses avoid negative, invasive biopsies.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now